Johns Hopkins University, Baltimore, Maryland, USA.
Am J Drug Alcohol Abuse. 2010 Jan;36(1):25-30. doi: 10.3109/00952990903544810.
HIV sexual-risk and drug-use behavior predictors have been studied in non-pregnant but not pregnant drug-dependent populations.
Examine the ability of the ASI composite scores to predict HIV sexual- and drug-risk scores as well as the individual items of a modified version of the Risk Assessment Battery in drug-using pregnant women.
Pregnant women (N = 76) completing pretreatment ASI and HIV-risk questionnaires.
The Legal composite score was the sole significant predictor of the sexual-risk score, with a 1 SD increase in the Legal composite score resulting in a 24% increase in sexual-risk, p < .001. The Medical, Drug, and Legal composite scores were each significant predictors of the drug-risk score, with a 1 SD increase resulting in a 31% decrease, and 121% and 73% increases, respectively, in drug-risk, all ps < .05.
Drug-using pregnant women and their fetuses are vulnerable to the consequences of both sexual-risk behaviors and drug-use. The ASI may help screen such patients for HIV sexual-risk and drug-use behaviors as a first step in tailoring treatment to address these issues.
已对非怀孕吸毒人群的 HIV 性风险和药物使用行为预测因素进行了研究,但尚未对怀孕吸毒人群进行研究。
检验 ASI 综合评分在预测怀孕吸毒女性的 HIV 性风险和药物风险评分,以及预测经改良的风险评估电池的各个项目方面的能力。
对接受治疗前的 ASI 和 HIV 风险问卷调查的 76 名孕妇进行评估。
法律综合评分是性风险评分的唯一显著预测因素,法律综合评分每增加一个标准差,性风险就会增加 24%,p <.001。医疗、药物和法律综合评分都是药物风险评分的显著预测因素,每个标准差的增加会导致药物风险分别降低 31%,增加 121%和 73%,所有 p 值均<.05。
吸毒的孕妇及其胎儿容易受到性风险行为和药物使用的后果的影响。ASI 可能有助于筛选此类患者的 HIV 性风险和药物使用行为,作为针对这些问题进行治疗的第一步。